Types segmentation classifies Enteral Feeding products into polymeric, disease‑specific, peptide‑based, modular, and fiber‑enriched formulas. Polymeric formulas, the baseline offering, comprise whole proteins, carbohydrates, and fats, and dominate the market because they meet the nutritional needs of the majority of patients without metabolic complications. Disease‑specific formulas—such as renal, hepatic, diabetic, and oncology variants—represent a growing niche, capturing higher price points by addressing organ‑specific metabolic demands; they now account for roughly 30 % of product volume. Peptide‑based formulas, containing hydrolysed proteins, are employed for patients with impaired digestion or high aspiration risk, adding a premium segment with slower volume growth but higher margins. Modular formulas allow clinicians to customise macronutrient ratios by adding separate protein, carbohydrate, or fat modules, supporting precise nutritional therapy in critical‑care environments. Fiber‑enriched formulas, incorporating soluble or insoluble fibers, aim to maintain gut integrity and reduce bacterial translocation. Each type contributes distinct revenue streams, and their combined share underpins the market taxonomy of Enteral Feeding.
